- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07841613
Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor Surgery
Studies have shown that compared to the evening, the platelet adhension and aggregation functions of normal individuals are stronger in the morning, reaching peak at around 8AM or 9AM. Fibrinolysis is weakest at 7-11AM, and most active at midnight. previous studies have been contradictory regarding the rhythm of plasmin. Some show the level of plasmin complexes is highest at night, while some show higher in the morning and some show there is no rhythmicity.
Since patients with tumors often have a hypercoagulable state, we try to find a method to assess whether cancer patients have the same circadian with heathy individuals. And whether the surgery time(in the morning or in the evening) will affect the tumor patients' postoperative coagulation function
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200333
- Fudan University Shanghai Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The subjects of the study were 83 patients scheduled for gastrointestinal tumor surgery under general anesthesia.
Description
Inclusion Criteria:
-
1) Patients who signed the informed consent form and were willing to complete the study according to the protocol.
2) Patients who underwent surgical treatment for digestive tract tumors. 3) The operation start time was from 8:00 to 9:00 in the morning and from 19:00 to 20:00 in the evening.
4) ASA grade I-II. 5) Age ranging from 20 to 70 years old.
Exclusion Criteria:
- 1) History of thrombosis-related diseases 2) Use of anticoagulants (excluding aspirin, which should be discontinued for one week) 3) Hb < 90g/dL 4) Diabetic patients [14] 5) Patients admitted to ICU after surgery 10) Those who have participated in other clinical trials or refused to join the study.
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_ONLY
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
morning surgery group
|
|
|
night surgery group
|
no intervention |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
preoperative TEG values
Time Frame: one day
|
one day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FudanU25.4.21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.